마이크로플루이딕 면역측정 시장 규모, 점유율 및 성장 분석 : 제품별, 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Microfluidic Immunoassay Market size was valued at USD 1.29 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 2.54 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The microfluidic immunoassay market is experiencing significant growth, driven by the need for improved patient care in resource-limited settings. Point-of-care (POC) testing is becoming increasingly accessible in hospitals, clinics, and homes, fueled by demographic changes and a demand for cost-effective, high-throughput diagnostic solutions. Despite ongoing challenges with current POC devices-such as sample pre-treatment requirements and inconsistent results-there is a notable shift towards miniaturized, lab-on-a-chip (LOC) systems. These systems offer advantages like reduced reagent consumption and rapid, accurate results. Factors contributing to market expansion include increased research in microfluidic technology, substantial venture capital investments in LOC-based diagnostics, the urgency of rapid decision-making in emergency care, and the rising prevalence of chronic diseases among the aging population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Immunoassay Market Segments Analysis

Global Microfluidic Immunoassay Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Cartridges, Polymer, Glass, Silicon, Reagents and Systems. Based on Technology, the market is segmented into Electrochemical Detection and Optical Detection. Based on Application, the market is segmented into Cardiology, Single Biomarker Detection, Multiplexed Biomarker Detection, Infectious Diseases, Oncology and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospital and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Immunoassay Market

The global microfluidic immunoassay market is poised for significant growth driven by various factors, particularly in emerging economies. Opportunities for expansion are enhanced by innovative technologies, such as paper-based microfluidics. Contributing to this growth are demographics characterized by an aging population alongside a large number of patients affected by both infectious and non-communicable diseases. Furthermore, increased funding for research and development, coupled with rising demand for high-quality healthcare services, greater disposable incomes, and advancements in healthcare infrastructure, collectively foster a favorable environment for the microfluidic immunoassay market to thrive.

Restraints in the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market faces several significant challenges that can impede its growth. One of the primary issues is the selection of appropriate substrate materials essential for the fabrication of microfluidic chips. Additionally, navigating the complexities of reimbursement processes can pose difficulties for manufacturers. Scaling production to meet mass-market demands remains another critical hurdle, as does the necessity to develop affordable products that can cater to the needs of less economically developed regions. Addressing these constraints is vital for maximizing the potential of this innovative market and ensuring broad accessibility to its benefits.

Market Trends of the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market is experiencing a notable trend driven by the increasing adoption of lab-on-chip (LOC) technology, which consolidates complex laboratory processes onto compact devices. This shift not only enhances portability but also reduces reliance on traditional bulky equipment. Particularly, paper-based microfluidic devices are garnering significant attention, especially for point-of-care (POC) applications in developing nations, owing to their cost-effectiveness and versatility. With the ability to facilitate fluid movement through capillary action without external forces, paper substrates are being extensively explored in both academic and commercial sectors, positioning themselves as a viable solution for various medical diagnostics and enhancing accessibility in healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Microfluidic Immunoassay Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
• Cartridges
• Polymer
• Glass
• Silicon
• Reagents
• Systems

Global Microfluidic Immunoassay Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Electrochemical Detection
• Optical Detection

Global Microfluidic Immunoassay Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cardiology
• Single Biomarker Detection
• Multiplexed Biomarker Detection
• Infectious Diseases
• Oncology
• Other Applications

Global Microfluidic Immunoassay Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospital
• Other End Users

Global Microfluidic Immunoassay Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Millipore (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wako Pure Chemical Industries, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations